Among the 36 cases, 21 patients underwent PD‐L1 tumor proportion score (TPS) testing, of which approximately 2/3 of the patients had an expression of > 50%; 11 patients underwent tumor mutational burden (TMB) testing, and about half of the patients had a TMB of ≥ 10 Mut/Mb. Here, CD274 is linked to neoplasm.